Literature DB >> 17163820

Measurement of late-night salivary cortisol with an automated immunoassay system.

Michael Vogeser1, Jürgen Durner, Ewald Seliger, Christoph Auernhammer.   

Abstract

BACKGROUND: Measurement of late-night salivary cortisol concentrations is increasingly used as a screening test in suspected Cushing's syndrome. Cortisol concentrations are typically extremely low in late-night samples and discordant assay-specific reference ranges have been reported. Therefore, the aim of our study was to assess the analytical performance of the first automated cortisol immunoassay specified for salivary measurements and to establish late-night sampling reference-range data for this test.
METHODS: Salivary cortisol was measured using the Roche Cobas Cortisol assay (Roche Diagnostics). Five salivary pools in different concentration ranges were used to assess the inter-assay imprecision of this test in a two-centre evaluation protocol including two reagent lots. Linearity was tested by serial dilution. Salivary samples were obtained at 23:00 h from 100 apparently healthy volunteers using a commercially available salivary sampling device (Salivette, Sarstedt). A subset of 20 samples was used for method comparison with isotope dilution liquid chromatography-tandem mass spectrometry.
RESULTS: Inter-assay coefficients of variation (n=20) between 11.6% and 40.4% were found for mean cortisol concentrations between 12.9 and 2.6 nmol/L, with an estimated functional sensitivity of approximately 5.0 nmol/L. The test also gave linear results in the lowest concentration range between 1.0 and 8.3 nmol/L. Mean late-night salivary cortisol of 5.0 nmol/L was found for healthy individuals; the absolute range was 1.4-16.7 nmol/L, and the 95th percentile was 8.9 nmol/L. Substantially lower concentrations were found with isotope dilution LC-MS/MS compared to immunoassay results (mean concentrations 1.8 and 4.4 nmol/L, respectively).
CONCLUSIONS: The automated assay investigated was found to offer acceptable analytical performance in the very low concentration range required for late-night salivary cortisol, despite a very short turn-around time. Using this assay, late-night salivary cortisol concentrations below 8.9 nmol/L are typically found in healthy volunteers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17163820     DOI: 10.1515/CCLM.2006.244

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  13 in total

1.  Diagnostic performance of late-night salivary cortisol measured by automated electrochemiluminescence immunoassay in obese and overweight patients referred to exclude Cushing's syndrome.

Authors:  Zhanna E Belaya; Alexander V Iljin; Galina A Melnichenko; Liudmila Y Rozhinskaya; Natalia V Dragunova; Larisa K Dzeranova; Svetlana A Butrova; Ekaterina A Troshina; Ivan I Dedov
Journal:  Endocrine       Date:  2012-03-25       Impact factor: 3.633

2.  Salivary cortisol and the diagnosis of Cushing's syndrome: a coming of age.

Authors:  Hershel Raff
Journal:  Endocrine       Date:  2012-06       Impact factor: 3.633

Review 3.  Cushing's syndrome: diagnosis and surveillance using salivary cortisol.

Authors:  Hershel Raff
Journal:  Pituitary       Date:  2012-03       Impact factor: 4.107

4.  Reducing Listening-Related Stress in School-Aged Children with Autism Spectrum Disorder.

Authors:  Gary Rance; Donella Chisari; Kerryn Saunders; Jean-Loup Rault
Journal:  J Autism Dev Disord       Date:  2017-07

5.  RAPID DEVELOPMENT OF IATROGENIC CUSHING SYNDROME IN A PATIENT ON RITONAVIR: THE ADVERSE METABOLIC CONSEQUENCE OF TOPICAL STEROID USE.

Authors:  Jeremy D Purser; Ruba Riachy; Lucas S Blanton; L Maria Belalcazar
Journal:  AACE Clin Case Rep       Date:  2020-09-24

6.  Label-Free Sensitive Detection of Steroid Hormone Cortisol Based on Target-Induced Fluorescence Quenching of Quantum Dots.

Authors:  Ye Liu; Bo Wu; Ekembu K Tanyi; Sanjida Yeasmin; Li-Jing Cheng
Journal:  Langmuir       Date:  2020-07-01       Impact factor: 3.882

7.  The relationship between cortisol and verbal memory in the early stages of Huntington's disease.

Authors:  Christopher A Shirbin; Phyllis Chua; Andrew Churchyard; Anthony J Hannan; Georgia Lowndes; Julie C Stout
Journal:  J Neurol       Date:  2012-11-20       Impact factor: 4.849

8.  Assessment of Pain, Anxiety, and Cortisol Levels During the Initial Aligning Phase of Fixed Orthodontic Treatment.

Authors:  Alev Aksoy; Mine Geçgelen Cesur; Birsen Harun Dağdeviren; Yasemin Alpağan Özkaynak; Gizem Karacin; Fatih Gültekin
Journal:  Turk J Orthod       Date:  2019-01-21

9.  Mindfulness-based Intervention for Female Adolescents with Chronic Pain: A Pilot Randomized Trial.

Authors:  Nicholas Chadi; Audrey McMahon; Majorie Vadnais; Catherine Malboeuf-Hurtubise; Anissa Djemli; Patricia L Dobkin; Jacques Lacroix; Thuy Mai Luu; Nancy Haley
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2016-11-01

10.  Depression, smoking, physical inactivity and season independently associated with midnight salivary cortisol in type 1 diabetes.

Authors:  Eva O Melin; Maria Thunander; Mona Landin-Olsson; Magnus Hillman; Hans O Thulesius
Journal:  BMC Endocr Disord       Date:  2014-09-16       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.